BioSpace

US explores China biotech restrictions, exempts licensing deals

A new proposal from the U.S. government seeking to address investment in Chinese biotech as a matter of national security drew cautious statements from across the industry, with leaders vowing to ensure innovation isn’t stifled.

By BioSpace

1 min read
US explores China biotech restrictions, exempts licensing deals
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights